IL6 and COVID-19: The failure of anti-IL6 therapy to produce major therapeutic effect in COVID-19 was recently explained by Jiang et al., who showed IL-6 interaction with the signalling glycoprotein gp-130 on the surface of T cells may occur with no involvement of IL-6R (Jiang Z et al., 2021).